-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead Unveils Promising Phase 2 CAR T-Cell Therapy Data for Blood Cancer at ASH 2025

Reuters·11/03/2025 14:10:38

Please log in to view news